Keyphrases
Oncolytic Adenovirus
100%
Pancreatic Cancer
91%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
64%
Virus
56%
Adenovirus
53%
Interferon-α (IFN-α)
51%
United States
51%
Chemotherapy
47%
Oncolytic Virus
41%
Surgeons
40%
Single Institution
34%
Hirsch Index
32%
Academic Productivity
32%
Breast Cancer
28%
National Institutes of Health Funding
28%
Breast Cancer Treatment
26%
Tumor
26%
Cytoreductive Surgery
25%
Ablation
23%
Pancreatic Ductal Adenocarcinoma
23%
Chemoradiation
23%
Conditionally Replicating Adenovirus
22%
Cancer Treatment
21%
Breast Cancer Patients
21%
Oncolytic Viral Therapy
21%
Surgical Oncology
21%
Confidence Interval
21%
Surgical Resection
20%
Academic Rank
20%
Overall Survival
19%
Human Sodium Iodide Symporter (hNIS)
19%
Liver Resection
18%
Microwave Ablation
18%
Estrogen Receptor-positive Breast Cancer
18%
Adenovirus Death Protein
18%
Improved Survival
18%
Hamster Model
18%
Odds Ratio
18%
Hepatic Metastasis
17%
Peritoneal Cancer Index
17%
Resection
17%
Patient Selection
17%
Oncolytic Virotherapy
16%
Cyclooxygenase-2
16%
Elective Surgery
16%
Nodal Metastasis
16%
Older Women
16%
Cancer Therapy
16%
Breast Reconstruction
16%
Administrative Database
16%
Medicine and Dentistry
Breast Cancer
79%
Pancreas Cancer
70%
Oncolytic Adenovirus
67%
Neoplasm
55%
Recurrent Disease
42%
Malignant Neoplasm
41%
Surgeon
40%
Adenoviridae
39%
Virus
37%
Cytoreductive Surgery
37%
Oncolytic Virus
37%
Chemoradiotherapy
33%
Overall Survival
32%
Microwave Thermotherapy
32%
Hyperthermic Intraperitoneal Chemotherapy
32%
Liver Metastasis
29%
Diseases
29%
Oncolytic Virotherapy
26%
Pancreas Adenocarcinoma
25%
Metastatic Carcinoma
23%
Cancer Therapy
23%
Surgical Oncology
23%
Computer Assisted Tomography
22%
Mastectomy
20%
Hepatectomy
20%
Immunotherapy
19%
Interferon
19%
Carcinomatous Peritonitis
18%
Retroperitoneal Lymph Node Dissection
18%
COVID-19
17%
Oncologist
17%
Estrogen Receptor Positive Breast Cancer
17%
Clinical Trial
17%
Adjuvant Therapy
17%
Patient Selection
17%
Cancer
17%
Cancer Cell
16%
Elective Surgery
16%
Liver Injury
16%
Patient Satisfaction
16%
Peritoneum Cancer
16%
Telemedicine
16%
Interferon Alfa
16%
Head and Neck Squamous Cell Carcinoma
16%
Nodal Metastasis
16%
Sentinel Lymph Node
16%
Axillary Lymph Node
16%
Cholinesterase
16%
Paclitaxel
16%
Gallbladder Cancer
16%